GATINEAU, QC, September 15th, 2022 – Pharmaflorx Inc. (“Pharmaflorx” or the”Company”) is delighted to announce the successful completion of its state-of-the-art facility, which has been under construction for the past three (3) years. This new facility is a testament to our unwavering dedication to providing cutting-edge technologies and innovations for indoor agriculture.
The new facility is situated in a prime location and covers an area of over 80,000 square feet, providing ample space for the company’s operations and ongoing business achievements. It features the latest equipment and technology, ensuring that Pharmaflorx can fulfill the demands of our customers with utmost efficiency and offer consistent high-quality products across the globe.
Pharmaflorx has invested significantly in the design and construction of this facility to ensure that it not only serves its intended function but also stands out with an aesthetically pleasing design. The facility’s design prioritizes the safety and comfort of employees, while biosafety is of utmost importance. The facility is designed to meet GMP standards, with certification expected to be obtained by Q4 of 2023.
The facility includes eighteen (18) independent grow rooms, a GMP post-harvest compliant area, and additional space to house a laboratory for tissue culture and genomic sequencing.
The company would like to express its heartfelt appreciation to all employees, contractors, and suppliers who have worked tirelessly to ensure the success of this project. Pharmaflorx eagerly anticipates continuing to provide its customers with the exceptional products that they have come to expect from us.
In conclusion, the completion of our new facility marks a significant milestone for our company, and we are excited to embark on this new chapter of our journey. The entire team looks forward to the future with confidence and renewed dedication to excellence.